This content is current only at the time of printing. This document was printed on 12 July 2020. A current copy is located at https://apvma.gov.au/node/15821
You are here
Proposed approval of a new active Buprenorphine and registration of the product Bupredyne Injection containing Buprenorphine
This consultation closed on 8 September 2015.
The APVMA is considering an application for the approval of a new active buprenorphine and registration of bupredyne injection. The product is to be used as an analgesic injection in dogs and cats.
We invite comment from 11 August 2015 to 8 September 2015 on whether the application for approval of the active constituent and/or registration of the product should be granted.
The APVMA is able to consider comments relating to the legislative grounds for registration, including:
- safety criteria
- efficacy criteria; and
- trade criteria
For more information see the APVMA Gazette Notice (page 21) from 11 August 2015
Please send your written submission by email, post or fax to:
Registration Management and Enquiries
Australian Pesticides and Veterinary Medicines Authority
PO Box 6182
Kingston ACT 2604
Fax: +61 2 6210 4721
Phone: +61 2 6210 4701